HOUGEN ELIZABETH L (CIK 1074773) reported 17 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-18). Recent activity: Buy IONS (20,541 shares), Buy IONS (61,041 shares), Buy IONS (33,118 shares), Buy IONS (60,299 shares), Sell IONS (205,608 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-18 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 20,541 | $771,931 |
| 2026-03-18 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 61,041 | $3.5M |
| 2026-03-18 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 33,118 | $1.1M |
| 2026-03-18 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 60,299 | $3.7M |
| 2026-03-18 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 205,608 | $14.9M |
| 2026-03-18 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 9,440 | $686,949 |
| 2026-03-18 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 10,172 | $744,692 |
| 2026-02-02 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 13,562 | $0 |
| 2026-02-02 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 6,988 | $581,681 |
| 2026-01-20 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 28,729 | $0 |
| 2026-01-20 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 12,922 | $971,993 |
| 2025-10-01 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 49,800 | $2.7M |
| 2025-10-01 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 49,800 | $3.2M |
| 2025-02-03 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 4,138 | $0 |
| 2025-02-03 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 1,523 | $49,406 |
| 2025-01-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Buy | 23,887 | $0 |
| 2025-01-17 | IONIS PHARMACEUTICALS INC (IONS) | EVP, Finance & CFO | Sell | 8,870 | $291,025 |
Source: SEC Form 4 filings · as of 2026-03-18